Evidence map›Paper›PMID 35905935›Full record

ReviewDrug discovery today2022

Impact of COVID-19 on male urogenital health: Success of vaccines.

Kutay Kucukyildiz, Didem Yilmaz-Oral, Damla Turkcan, Cetin Volkan Oztekin, Serap Gur

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Drug discovery today, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kutay KucukyildizDepartment of Pharmacology, Faculty of Pharmacy, Ankara University, Ankara, Turkey.
Didem Yilmaz-OralDepartment of Pharmacology, Faculty of Pharmacy, Cukurova University, Adana, Turkey.
Damla TurkcanDepartment of Pharmacology, Faculty of Pharmacy, Ankara University, Ankara, Turkey.
Cetin Volkan OztekinDepartment of Urology, Faculty of Medicine, University of Kyrenia, Girne-TRNC, Mersin 10, Turkey.
Serap GurDepartment of Pharmacology, Faculty of Pharmacy, Ankara University, Ankara, Turkey. Electronic address: serapgur@ankara.edu.tr.
Ankara University · TRCukurova University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Throughout 2021, the scientific and medical communities were concentrated on dealing with the acute morbidity and mortality induced by the COVID-19 pandemic due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We reviewed the present data for adverse effects of COVID-19 on the different parts of the male urogenital system during the dynamic situation of the COVID-19 pandemic. With the approval of COVID-19 vaccinations, there is a ray of hope at the end of this dark tunnel and a chance to look ahead for the management of long-term consequences in males with urogenital illness. A multidisciplinary investigation of these cases could provide information for establishing and optimizing treatment protocols.

Indexed as

COVID-19VaccinesAngiotensin-Converting Enzyme 2HumansMalePandemicsPeptidyl-Dipeptidase ASARS-CoV-2Urogenital SystemAngiotensin-Converting Enzyme 2Peptidyl-Dipeptidase AVaccinesAngiotensin-converting enzyme 2COVID-19Erectile dysfunctionProstateUrinary bladder

Identifiers

PMID35905935
PMCPMC9316714
OpenAlexW4288045288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.